It is a disturbing revelation that Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, has been receiving royalty payments from companies that license his inventions. According to new reports, Fauci and his colleague Dr. Francis Collins have received a total of 58 royalty payments from companies that have used their inventions developed with taxpayer money. This raises serious concerns about the integrity and accountability of the NIH and its officials.
The records obtained by transparency watchdog group OpenTheBooks.com reveal that the NIH has collected more than $325 million in licensing fees from these companies in the past three years alone. It is concerning that these payments are not publicly disclosed and have only come to light after a lengthy Freedom of Information Act battle. This lack of transparency does not inspire confidence in how the NIH is handling taxpayer funds.
Drugmakers in 31 foreign countries—including China, Russia, and Belarus—paid hundreds of millions of dollars in royalties to top #NIH officials, including Drs. Francis Collins and Anthony Fauci, according to royalty payments made public by @Open_The_Books. https://t.co/Y5pxbtDFZn
— The Epoch Times (@EpochTimes) August 12, 2023
What is even more troubling is that out of these deposits, Fauci has received 37 payments from just three companies between 2010-2021. This raises questions about why Fauci and Collins were heavily monetized while other researchers were not given the same opportunity. Is there a conflict of interest at play here? Was Fauci using his position for personal gain? These are serious questions that demand answers.
It is alarming that Fauci received 15 payments from Santa Cruz Biotechnology, which creates products for medical research. He also received payments from Ancell Corp. and Chiron Corp., both involved in immunology research. This raises concerns about the influence these payments may have had on the NIH’s decision-making process. In a time when healthcare costs are skyrocketing, it is unacceptable for NIH officials to be receiving large sums of money from companies they are supposed to regulate.
Furthermore, this situation calls into question the transparency and accountability of the NIH. Taxpayer money should be used for medical research, not for personal gain or private interests. These royalty payments should have been publicly disclosed, and the fact that they were not raises doubts about the fairness and integrity of the system.
FAUCI THE FRAUD STRIKES AGAIN | TO THE TUNE OF $325 MILLION https://t.co/z15pEko7cm
— John Solomon (@jsolomonReports) August 11, 2023
The lack of transparency and potential conflicts of interest also warrant further investigation. It is imperative that we determine if pay-to-play politics played a role in how the NIH distributed its funds. Dr. Fauci’s leadership, in particular, must be investigated thoroughly. The American people deserve to know if their hard-earned money is being used for the right reasons and not for personal gain.
I think we all know that it is deeply concerning that Dr. Anthony Fauci has been receiving royalty payments from companies that license his inventions. This raises questions about conflicts of interest and the accountability of the NIH.
Transparency and fair distribution of taxpayer funds are crucial for the proper functioning of the agency. The American people deserve answers and concrete action must be taken to ensure that such instances do not occur in the future. As investigations continue, it is essential that we hold our public officials accountable for their actions, especially when it comes to the use of public funds.